Cohn EJ, Oncley JL, Strong LE, Hughes WL and Armstrong SH. Chemical, clinical, and immunological studies on the products of human plasma fractionation. I. The characterization of the protein fractions of human plasma. J. Clin. Investing. (1944) 23 (4): 417-32.
 Stiehm ER, Vaerman JP and Fudenberg HH. Plasma infusions in immunologic deficiency states: metabolic and therapeutic studies. Blood (1966) 28 (6): 918-37.
 Barandun S, Kistler P, Jeunet F and Isliker H. Intravenous administration of human gamma-globulin. Vox. Sang. (1962) 7: 157-74.
 Ammann AJ, Ashman RF, Buckley RH, Hardie WR, Krantmann HJ and Nelson J. Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial. Clin. Immunol. Immunopathol. (1982) 22 (1): 60-7.
 Cunningham-Rundles C, Siegal FP, Smithwick EM, Lion-Boule A, Cunningham-Rundles S and O'Malley J. Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. Ann. Intern. Med. (1984) 101(4): 435-9.
 Buckley RH and Schiff RI. The use of intravenous immune globulin in immunodeficiency diseases. N. Engl. J. Med. (1991) 325 (2): 110-7.
 Milgrom H. Shortage of intravenous immunoglobulin. Ann. Allergy. Asthma. Immunol. (1998) 81(2): 97-100.
 Farrugia A and Poulis P. Intravenous immunoglobulin: regulatory perspectives on use and supply. Transfus. Med. (2001) 11(2): 63-74.
 Burnouf T. Chromatography in plasma fractionation: benefits and future trends. J. Chromatogr, B, Biomed. Sci. Appl. (1995) 664 (1): 3-15.
 Shin IS, Shim YB, Hong CM, Koh HC, Lee SH and Hong SH. An improved, reliable and practical kinetic assay for the detection of prekallikrein activator in blood products. Arch. Pharm. Res. (2002) 25(4): 505-10.
 Kaplan AP, Joseph K and Silverberg M. Pathways for bradykinin formation and inflammatory disease. J. Allergy. Clin. Immunol. (2002) 109 (2): 195-209.
 European Pharmacopoeia: Human normal immunoglobulin for intravenous administration. European Pharmacopoeia 6.3, monograph 2.6.17. 4166–8. Council of Europe, Strasbourg Cedex, France.
 Cheraghali AM and Abolghasemi H. Improving availability and affordability of plasma-derived medicines. Biologicals. (2010) 38 (1):81-6.
 Burnouf T. Plasma fractionation. ISBT Vox Sang. (2012) 7: 62–67.
 Tanaka K, Sawatani E, Dias G, Shigueoka E, Campos T, Nakao H and Arashiro F. High quality human immunoglobulin G purified from Cohn fractions by liquid chromatography. Braz. J. Med. Biol. Res. (2000) 33: 27-30.
 Lebing W, Remington K, Schreiner C and Paul HI. Properties of a new intravenous immunoglobulin (IGIV‐C, 10%) produced by virus inactivation with caprylate and column chromatography. Vox Sang. (2003) 84: 193-201.
 Sisti A, Vitali M, Manfredi M and Zarzur J. Preparation of lyophilized and liquid intravenous immunoglobulin G: development and scale‐up. Vox Sang. (2001) 80: 216-24.
 Pierce LR and Jain N. Risks associated with the use of intravenous immunoglobulin. Transfus. Med. Rev. (2003) 17(4):241-51.
 Nezlin R. Interactions between immunoglobulin G molecules. Immunol. Lett. (2010) 132(1-2):1-5.